Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$40.29 - $82.51 $24,174 - $49,506
-600 Reduced 3.24%
17,900 $742,000
Q1 2023

May 15, 2023

BUY
$56.44 - $118.81 $5,644 - $11,881
100 Added 0.54%
18,500 $1.11 Million
Q3 2022

Nov 14, 2022

BUY
$67.99 - $89.57 $6,798 - $8,957
100 Added 0.55%
18,400 $1.4 Million
Q1 2022

May 13, 2022

SELL
$60.15 - $84.52 $18,045 - $25,356
-300 Reduced 1.61%
18,300 $1.52 Million
Q4 2021

Feb 14, 2022

BUY
$75.08 - $121.99 $7,508 - $12,199
100 Added 0.54%
18,600 $1.4 Million
Q3 2021

Nov 16, 2021

SELL
$116.17 - $194.55 $104,553 - $175,095
-900 Reduced 4.64%
18,500 $2.15 Million
Q2 2021

Aug 16, 2021

BUY
$130.4 - $225.58 $13,040 - $22,558
100 Added 0.52%
19,400 $4.3 Million
Q1 2021

May 17, 2021

SELL
$124.11 - $190.17 $99,288 - $152,136
-800 Reduced 3.98%
19,300 $2.55 Million
Q4 2020

Feb 16, 2021

BUY
$112.16 - $174.14 $112,160 - $174,140
1,000 Added 5.24%
20,100 $3.48 Million
Q3 2020

Nov 16, 2020

BUY
$58.05 - $111.31 $11,610 - $22,262
200 Added 1.06%
19,100 $2.13 Million
Q2 2020

Aug 13, 2020

BUY
$57.2 - $74.41 $343,200 - $446,460
6,000 Added 46.51%
18,900 $1.12 Million
Q1 2020

May 15, 2020

BUY
$57.05 - $95.75 $735,945 - $1.24 Million
12,900 New
12,900 $869,000

Others Institutions Holding NVCR

About NovoCure Ltd


  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $3.23B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track Utah Retirement Systems Portfolio

Follow Utah Retirement Systems and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Utah Retirement Systems, based on Form 13F filings with the SEC.

News

Stay updated on Utah Retirement Systems with notifications on news.